UC San Diego’s Daniel Green set out to find a signal for the quantum origin of structure by applying theoretical techniques used to understand the way particles scatter in colliders.
UC San Diego Health and the Altman Clinical and Translational Research Institute will be sites for an accelerated national clinical trial to assess the efficacy and immunogenicity of a vaccine intended to protect against SARS-CoV-2, the coronavirus that causes COVID-19.
In the midst of the unprecedented COVID-19 pandemic that had UC San Diego researchers racing to understand the complexities around the virus’s spread and to find ways to combat it, engineers and fabrication specialists at the Qualcomm Institute’s Prototyping Lab leapt into action.
What is the goal of the Return to Learn program? What role does testing play in preventing an outbreak? UC San Diego infectious disease modeler Natasha Martin addresses top questions from the campus community.
Cancer doesn’t stop because of a pandemic. People diagnosed with cancer must continue lifesaving treatment. Sometimes the only options are clinical trials. That is why, despite some modifications, UC San Diego Health has continued its cancer clinical trial enrollment.
With a bottom-up approach to synthetic biology, UC San Diego Chemist Neal Devaraj, Physicist Sunil Sinha and a team of researchers showed that lipid sponge droplets can be programmed to function like cellular organelles.
Keep up with all the latest from UC San Diego. Subscribe to the newsletter today.
